Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Buzz on the Bullboards: A Light at the end of the COVID Tunnel for Capital Markets?

(Image via Therma Bright Inc.) This is another time of renewed uncertainty in the markets and investors are once again focusing on most consistent plays. Increases in COVID-19 cases and worries over the state of the economy caused this recent wave of uncertainty...
Stockhouse Editorial | May 12, 2021 |

No Rules, No Game, No Spectators

There are times in my life where I am forced to fight the urge to do harm to people, something that I have never enjoyed, even when I was playing hockey in the violent Southern Hockey League in 1977. I have taken spears to the groin, butt-ends to the face, hooks to...
Streetwise Reports | March 10, 2020 |

Oil & Gas Explorer Meets 'Capital Discipline Goals' Despite NGL Price Weakness

A Raymond James report looks at 2019, 2020 spending and production expectations for and by this company. In a July 18 research note, John Freeman reported that Raymond James decreased its target price but maintained its Outperform rating on SM Energy Co. (S...
Streetwise Reports | July 24, 2019 |

Negative Rates, Access to Deal Flow and a First Time Ever for Doug Casey

Doug is a legend in the business. Like with most legends, comes the peanut gallery that try to bash what he has accomplished to have their dorky voices heard among the roar of a legend. Ask yourself this, these trolls who bash, what have they accomplished? Doug has ...
Marin Katusa | November 1, 2019 |

Buzz on the Bullboards: Key Goals Behind Top Investor’s Moves

(Image via HEXO Corp.) At Stockhouse, investor focus is on companies whose valuations seem a little more firmly rooted in down on planet Earth. When it comes to the most popular stocks over the previous week, three names are dominating, especially where health care ...
Stockhouse Editorial | September 22, 2021 |

Why Pan Orient Energy Is a Favorite

Pan Orient Energy Corp. (POE:TSX.V) is a simple story; it was clearly described in its Valentine's Day press release and the presentation on its website. Pan Orient has about ~70c CAD in cash per share and Thailand 2P reserve worth about ~70c CAD per share, and it...
Streetwise Reports | February 27, 2019 |

Aravive Shares Rise on Positive Patient Data from Phase 1b Ovarian Cancer Study

Shares of Aravive Inc. are trading higher after the firm posted positive data from the initial 12 patients enrolled in the Phase 1b portion of its study of AVB-500 used in the treatment of ovarian cancer. Today, in a late-breaking oral presentation at the European Soc...
Streetwise Reports | September 30, 2019 |

Zynex Shares Trade Higher After Reporting a 95% Increase in Q3 Orders

Non-invasive medical device maker Zynex Inc's. shares are trading 12% higher on an overall down market day after the company reported that Q3/19 orders are up 95% over the same period in 2018. This morning medical technology company specializing in manufacturing and s...
Streetwise Reports | October 3, 2019 |

Coverage Initiated on U.S.-Based Precision Therapy Developer

The key reasons this story is compelling are given in an H.C. Wainwright & Co. report. In an Oct. 3 research note, analyst Andrew Fein reported that H.C. Wainwright & Co. initiated coverage on Blueprint Medicines Corp. (BPMC:NASDAQ) with a Buy rating and a $100 per ...
Streetwise Reports | October 9, 2019 |

Coverage Initiated on Maker of Antibiotic-Free Supplement for Livestock Feed

The highlights of this investment story are outlined in a Zacks Small-Cap Research report. In a Nov. 19 research note, analyst David Bautz reported that Zacks Small-Cap Research initiated coverage on Avivagen Inc. (VIV:TSX.V; CHEXF:OTCMKTS) with a US$2.50 valuation....
Streetwise Reports | November 27, 2019 |
1 2 3 4 5 6 7 8 9 10 ...